Task: Answer the multiple choice question.
Question: Which drug exhibits a -0.477\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CCOC(=O)C1CCCN(CC(O)COc2cccc(C)c2)C1.Cl
[b] CC1CC(CCC(=O)NC(=S)Nc2ccc(Cl)cn2)C(=O)O1
Answer: b. CC1CC(CCC(=O)NC(=S)Nc2ccc(Cl)cn2)C(=O)O1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CC(CCC(=O)NC(=S)Nc2ccc(Cl)cn2)C(=O)O1
CC1CC(CCC(=O)NC(=S)Nc2ccc(Cl)cn2)C(=O)O1
N-[(5-chloropyridin-2-yl)carbamothioyl]-3-(5-methyl-2-oxooxolan-3-yl)propanamide